home / stock / crdf / crdf news


CRDF News and Press, Cardiff Oncology Inc. From 11/02/23

Stock Information

Company Name: Cardiff Oncology Inc.
Stock Symbol: CRDF
Market: NASDAQ

Menu

CRDF CRDF Quote CRDF Short CRDF News CRDF Articles CRDF Message Board
Get CRDF Alerts

News, Short Squeeze, Breakout and More Instantly...

CRDF - Cardiff Oncology, Inc. (CRDF) Q3 2023 Earnings Call Transcript

2023-11-02 21:11:03 ET Cardiff Oncology, Inc. (CRDF) Q3 2023 Earnings Conference Call November 02, 2023, 16:30 ET Company Participants Kiki Patel - IR, Gilmartin Group Mark Erlander - CEO Jamie Levine - CFO Conference Call Participants Mark Frahm - TD...

CRDF - Cardiff Oncology GAAP EPS of -$0.22 beats by $0.06, revenue of $0.14M beats by $0.1M

2023-11-02 16:42:20 ET More on Cardiff Oncology Cardiff Oncology (CRDF) Investor Presentation - Slideshow Cardiff Oncology: How The Recommitment Shapes The Investment Thesis (Rating Upgrade) Biggest stock movers today: Cloudflare, NextEra Energy Partners, ChargePoint...

CRDF - Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update

Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update PR Newswire - Advance to first-line RAS-mutated metastatic colorectal cancer (mCRC) for lead program based on positive clinical and preclinical data and guidance from FDA - - Expanded rela...

CRDF - Expected US Company Earnings on Thursday, November 2nd, 2023

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

CRDF - Expected earnings - Cardiff Oncology Inc.

Cardiff Oncology Inc. (CRDF) is expected to report $-0.29 for Q3 2023

CRDF - Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update

Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update PR Newswire - Management will hold a conference call on Thursday, November 2 at 4:30 p.m. ET / 1:30 p.m. PT - SAN DIEGO , Oct. 26, 2023 /PRNewswire/ --...

CRDF - Rising Number of Studies to Develop Novel Therapies For Pancreatic Ductal Adenocarcinoma (PDAC) Intensely Increasing

2023-10-23 08:45:38 ET Palm Beach, FL – October 23, 2023 – FinancialNewsMedia.com News Commentary – Pancreatic ductal adenocarcinoma (PDAC) is a fatal malignancy of both the digestive system and endocrine system with disappointing prognoses. The number of ne...

CRDF - CRDF, ASTI and PIXY among pre-market losers

2023-09-28 08:24:45 ET More on Ascent Solar Technologies, Cardiff Oncology, etc. Cardiff Oncology (CRDF) Investor Presentation - Slideshow Cardiff Oncology: How The Recommitment Shapes The Investment Thesis (Rating Upgrade) Biggest stock movers today: Cloudflare, Nex...

CRDF - 24/7 Market News Snapshot 27 Sept 2023

2023-09-27 09:55:35 ET DENVER, Colo., Sept 27, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ShiftPixy Inc (NASDAQ: PIXY), Galecto Inc (NASDAQ: GLTO), Cardiff Oncology Inc (NASDAQ: CRDF), American Strat...

CRDF - Cardiff Oncology Announces Positive Onvansertib Monotherapy Clinical Data

2023-09-27 07:42:23 ET (24/7 MARKET NEWS) – Cardiff Oncology, Inc. (NASDAQ: CRDF) reported, after yesterday’s market close, positive clinical data with onvansertib monotherapy and combination therapy in our ongoing trials in metastatic pancreatic ductal adenocarcinoma (mPDAC) ...

Previous 10 Next 10